These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 15713891

  • 1. (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer.
    Xu L, Yang D, Wang S, Tang W, Liu M, Davis M, Chen J, Rae JM, Lawrence T, Lippman ME.
    Mol Cancer Ther; 2005 Feb; 4(2):197-205. PubMed ID: 15713891
    [Abstract] [Full Text] [Related]

  • 2. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q, Ji M, Pienta K, Lawrence T, Xu L.
    Mol Cancer Ther; 2008 Jul; 7(7):2192-202. PubMed ID: 18645028
    [Abstract] [Full Text] [Related]

  • 3. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment.
    Akagunduz O, Karaca B, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Haydaroglu A, Uslu R.
    J BUON; 2010 Jul; 15(4):763-7. PubMed ID: 21229643
    [Abstract] [Full Text] [Related]

  • 4. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.
    Pang X, Wu Y, Wu Y, Lu B, Chen J, Wang J, Yi Z, Qu W, Liu M.
    Mol Cancer Ther; 2011 May; 10(5):795-805. PubMed ID: 21372225
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
    Zhang XQ, Huang XF, Mu SJ, An QX, Xia AJ, Chen R, Wu DC.
    Asian J Androl; 2010 May; 12(3):390-9. PubMed ID: 20081872
    [Abstract] [Full Text] [Related]

  • 6. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.
    Lian J, Wu X, He F, Karnak D, Tang W, Meng Y, Xiang D, Ji M, Lawrence TS, Xu L.
    Cell Death Differ; 2011 Jan; 18(1):60-71. PubMed ID: 20577262
    [Abstract] [Full Text] [Related]

  • 7. Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts.
    Anai S, Goodison S, Shiverick K, Hirao Y, Brown BD, Rosser CJ.
    Mol Cancer Ther; 2007 Jan; 6(1):101-11. PubMed ID: 17237270
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.
    Lian J, Ni Z, Dai X, Su C, Smith AR, Xu L, He F.
    Mol Cancer Ther; 2012 Feb; 11(2):416-26. PubMed ID: 22188816
    [Abstract] [Full Text] [Related]

  • 9. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: overcoming radiation- and mda-7/IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2.
    Su ZZ, Lebedeva IV, Sarkar D, Emdad L, Gupta P, Kitada S, Dent P, Reed JC, Fisher PB.
    Oncogene; 2006 Apr 13; 25(16):2339-48. PubMed ID: 16331261
    [Abstract] [Full Text] [Related]

  • 10. Induction of apoptosis and antitumor effects of a small molecule inhibitor of Bcl-2 and Bcl-xl, gossypol acetate, in multiple myeloma in vitro and in vivo.
    Lin J, Wu Y, Yang D, Zhao Y.
    Oncol Rep; 2013 Aug 13; 30(2):731-8. PubMed ID: 23708869
    [Abstract] [Full Text] [Related]

  • 11. Nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line.
    Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, Sarkar FH.
    Pancreas; 2005 Nov 13; 31(4):317-24. PubMed ID: 16258364
    [Abstract] [Full Text] [Related]

  • 12. In vivo evaluation of AT-101 (R-(-)-gossypol acetic acid) in androgen-independent growth of VCaP prostate cancer cells in combination with surgical castration.
    Loberg RD, McGregor N, Ying C, Sargent E, Pienta KJ.
    Neoplasia; 2007 Dec 13; 9(12):1030-7. PubMed ID: 18084610
    [Abstract] [Full Text] [Related]

  • 13. In vitro effects of the BH3 mimetic, (-)-gossypol, on head and neck squamous cell carcinoma cells.
    Oliver CL, Bauer JA, Wolter KG, Ubell ML, Narayan A, O'Connell KM, Fisher SG, Wang S, Wu X, Ji M, Carey TE, Bradford CR.
    Clin Cancer Res; 2004 Nov 15; 10(22):7757-63. PubMed ID: 15570010
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.
    Ritter V, Krautter F, Klein D, Jendrossek V, Rudner J.
    Cell Death Dis; 2021 Jul 13; 12(7):694. PubMed ID: 34257274
    [Abstract] [Full Text] [Related]

  • 15. AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.
    Zerp SF, Stoter R, Kuipers G, Yang D, Lippman ME, van Blitterswijk WJ, Bartelink H, Rooswinkel R, Lafleur V, Verheij M.
    Radiat Oncol; 2009 Oct 23; 4():47. PubMed ID: 19852810
    [Abstract] [Full Text] [Related]

  • 16. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
    McGregor N, Patel L, Craig M, Weidner S, Wang S, Pienta KJ.
    J Cell Biochem; 2010 Aug 01; 110(5):1187-94. PubMed ID: 20589722
    [Abstract] [Full Text] [Related]

  • 17. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K, Takei Y.
    Int J Cancer; 2009 Dec 15; 125(12):2978-90. PubMed ID: 19422046
    [Abstract] [Full Text] [Related]

  • 18. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang JM, Yang DJ.
    Acta Pharmacol Sin; 2008 Dec 15; 29(12):1467-77. PubMed ID: 19026166
    [Abstract] [Full Text] [Related]

  • 19. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
    Huang YW, Wang LS, Chang HL, Ye W, Dowd MK, Wan PJ, Lin YC.
    Anticancer Res; 2006 Dec 15; 26(3A):1925-33. PubMed ID: 16827126
    [Abstract] [Full Text] [Related]

  • 20. AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer.
    Moretti L, Li B, Kim KW, Chen H, Lu B.
    J Thorac Oncol; 2010 May 15; 5(5):680-7. PubMed ID: 20354451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.